Eric J. Wang
Johns Hopkins University
21 Papers
2 Citations
Eric J. Wang is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 3 publications.
Chat about Author
Papers
Chronic pain and infection: mechanisms, causes, conditions, treatments, and controversies
TL;DR: Although antimicrobial treatment might have a role in treating chronic pain states that involve active infectious inflammatory processes, their use in chronic pain conditions resulting from autoimmune mechanisms, central sensitization and irrevocable tissue are likely to cause more harm than benefit.
36
Blood utilization and mortality in victims of gun violence
Vincent M. DeMario,Robert A. Sikorski,David T. Efron,Mara A. Serbanescu,Rica M. Buchanan,Eric J. Wang,Mereze Visagie,Eric A. Gehrie,Mariuxi C. Manukyan,Kathy Noll,K.H. Ken Lee,Paul M. Ness,Steven M. Frank,Steven M. Frank +13 more
TL;DR: Blood transfusion can be lifesaving for patients with hemorrhage; however, transfusion requirements for victims of gun violence are poorly understood.
31
Implantable Peripheral Nerve Stimulation for Peripheral Neuropathic Pain: A Systematic Review of Prospective Studies
S. Char,Max Y. Jin,Vinicius Tieppo Francio,Nasir Hussain,Eric J. Wang,Mahmoud Morsi,Vwaire Orhurhu,Larry J. Prokop,Adam Benjamin Fink,Ryan S D'Souza +9 more
TL;DR: Overall, pooled results demonstrate very low quality or low quality of evidence supporting modest to substantial improvement in pain and neurological function after PNS implantation for treatment of peripheral neuropathic pain.
Methodological and statistical characteristics of meta-analyses on spinal cord stimulation for chronic pain: a systematic review.
Donald Kleppel,Royce Copeland,Nasir Hussain,Eric J. Wang,Ryan S D'Souza +4 more
TL;DR: A critically low AMSTAR-2 quality for most MAs published on the use of SCS for treating chronic pain is demonstrated, and future MAs should improve study quality by implementing the AMSTAR-2 checklist items.
Safety of Scrambler Therapy: A Systematic Review of Complications and Adverse Effects.
Eric J. Wang,Gerard Limerick,Ryan S D'Souza,Katie Lobner,Kayode Williams,Steven P. Cohen,Thomas J. Smith +6 more
TL;DR: When used in accordance with the treatment protocols described by the United States Food and Drug Administration and device manual, ST is associated with a reported composite complication rate that is magnitudes of order lower than that of invasive neuromodulation devices.
5